Cargando…

Cluster headache and kynurenines

BACKGROUND: The glutamatergic neurotransmission has important role in the pathomechanism of primary headache disorders. The kynurenine metabolites derived from catabolism of tryptophan (Trp) have significant involvement not only in glutamatergic processes, but also in the neuroinflammation, the oxid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tuka, Bernadett, Körtési, Tamás, Nánási, Nikolett, Tömösi, Ferenc, Janáky, Tamás, Veréb, Dániel, Szok, Délia, Tajti, János, Vécsei, László
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Milan 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074689/ https://www.ncbi.nlm.nih.gov/pubmed/37016290 http://dx.doi.org/10.1186/s10194-023-01570-9

Ejemplares similares

Clinical relevance of depressed kynurenine pathway in episodic migraine patients: potential prognostic markers in the peripheral plasma during the interictal period
por: Tuka, Bernadett, et al.
Publicado: (2021)

Release of PACAP-38 in episodic cluster headache patients – an exploratory study
por: Tuka, Bernadett, et al.
Publicado: (2016)

The effect of orofacial complete Freund’s adjuvant treatment on the expression of migraine-related molecules
por: Körtési, Tamás, et al.
Publicado: (2019)

Kynurenic Acid Inhibits the Electrical Stimulation Induced Elevated Pituitary Adenylate Cyclase-Activating Polypeptide Expression in the TNC
por: Körtési, Tamás, et al.
Publicado: (2018)

From CGRP to PACAP, VIP, and Beyond: Unraveling the Next Chapters in Migraine Treatment
por: Tanaka, Masaru, et al.
Publicado: (2023)

Are Migraine With and Without Aura Really Different Entities?
por: Kincses, Zsigmond Tamás, et al.
Publicado: (2019)

Interictal brain activity differs in migraine with and without aura: resting state fMRI study
por: Faragó, Péter, et al.
Publicado: (2017)

Disease- and headache-specific microRNA signatures and their predicted mRNA targets in peripheral blood mononuclear cells in migraineurs: role of inflammatory signalling and oxidative stress
por: Aczél, Timea, et al.
Publicado: (2022)

White matter disintegration in cluster headache
por: Szabó, Nikoletta, et al.
Publicado: (2013)

Neurotransmitter and tryptophan metabolite concentration changes in the complete Freund’s adjuvant model of orofacial pain
por: Cseh, Edina K., et al.
Publicado: (2020)

Identification of disease- and headache-specific mediators and pathways in migraine using blood transcriptomic and metabolomic analysis
por: Aczél, Timea, et al.
Publicado: (2021)

Evidence for Plastic Processes in Migraine with Aura: A Diffusion Weighted MRI Study
por: Szabó, Nikoletta, et al.
Publicado: (2018)

Chronic Migraine as a Primary Chronic Pain Syndrome and Recommended Prophylactic Therapeutic Options: A Literature Review
por: Szok, Délia, et al.
Publicado: (2023)

Treatment of Chronic Migraine with OnabotulinumtoxinA: Mode of Action, Efficacy and Safety
por: Szok, Délia, et al.
Publicado: (2015)

Therapeutic Approaches for Peripheral and Central Neuropathic Pain
por: Szok, Délia, et al.
Publicado: (2019)

Altered Resting State Functional Activity and Microstructure of the White Matter in Migraine With Aura
por: Faragó, Péter, et al.
Publicado: (2019)

Exploring Novel Therapeutic Targets in the Common Pathogenic Factors in Migraine and Neuropathic Pain
por: Tajti, János, et al.
Publicado: (2023)

Kynurenines, neurodegeneration and Alzheimer’s disease
por: Kincses, Zsigmond Tamas, et al.
Publicado: (2010)

Kynurenines in the Pathogenesis of Multiple Sclerosis: Therapeutic Perspectives
por: Biernacki, Tamás, et al.
Publicado: (2020)

PACAP and its role in primary headaches
por: Edvinsson, Lars, et al.
Publicado: (2018)

Exploring the Tryptophan Metabolic Pathways in Migraine-Related Mechanisms
por: Körtési, Tamás, et al.
Publicado: (2022)

TRP Channels: Recent Development in Translational Research and Potential Therapeutic Targets in Migraine
por: Spekker, Eleonóra, et al.
Publicado: (2022)

The Tryptophan-Kynurenine Metabolic System Is Suppressed in Cuprizone-Induced Model of Demyelination Simulating Progressive Multiple Sclerosis
por: Polyák, Helga, et al.
Publicado: (2023)

Changing the Face of Kynurenines and Neurotoxicity: Therapeutic Considerations
por: Bohár, Zsuzsanna, et al.
Publicado: (2015)

Exploiting the Therapeutic Potential of Endogenous Immunomodulatory Systems in Multiple Sclerosis—Special Focus on the Peroxisome Proliferator-Activated Receptors (PPARs) and the Kynurenines
por: Fakan, Bernadett, et al.
Publicado: (2019)

Are Kynurenines Accomplices or Principal Villains in Dementia? Maintenance of Kynurenine Metabolism
por: Tanaka, Masaru, et al.
Publicado: (2020)

EHMTI-0189. Tryptophan-kynurenine metabolism in migraine patients
por: Majláth, Z, et al.
Publicado: (2014)

Memory Enhancement with Kynurenic Acid and Its Mechanisms in Neurotransmission
por: Martos, Diána, et al.
Publicado: (2022)

O066. Kynurenine pathway metabolites in cluster headache
por: Curto, Martina, et al.
Publicado: (2015)

The Genetic Link between Parkinson's Disease and the Kynurenine Pathway Is Still Missing
por: Török, Nóra, et al.
Publicado: (2015)

Transformation of Meloxicam Containing Nanosuspension into Surfactant-Free Solid Compositions to Increase the Product Stability and Drug Bioavailability for Rapid Analgesia
por: Bartos, Csaba, et al.
Publicado: (2019)

Kynurenines and Neurofilament Light Chain in Multiple Sclerosis
por: Pukoli, Dániel, et al.
Publicado: (2021)

Altered serum levels of kynurenine metabolites in patients affected by cluster headache
por: Curto, Martina, et al.
Publicado: (2016)

Immunomodulatory Effects of Genetic Alterations Affecting the Kynurenine Pathway
por: Boros, Fanni A., et al.
Publicado: (2019)

Effects of sub-chronic, in vivo administration of sigma-1 receptor ligands on platelet and aortic arachidonate cascade in streptozotocin-induced diabetic rats
por: Váczi, Sándor, et al.
Publicado: (2022)

Interactions between the Kynurenine and the Endocannabinoid System with Special Emphasis on Migraine
por: Nagy-Grócz, Gábor, et al.
Publicado: (2017)

Kynurenine Metabolites and Migraine: Experimental Studies and Therapeutic Perspectives
por: Fejes, Annamária, et al.
Publicado: (2011)

Kynurenines and the Endocannabinoid System in Schizophrenia: Common Points and Potential Interactions
por: Zádor, Ferenc, et al.
Publicado: (2019)

Kynurenines and Multiple Sclerosis: The Dialogue between the Immune System and the Central Nervous System
por: Rajda, Cecilia, et al.
Publicado: (2015)

Mitochondria, Oxidative Stress and the Kynurenine System, with a Focus on Ageing and Neuroprotection
por: Sas, Katalin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_r6ihngb7ssmbtshgp7hhm93bvv